MCID: MCR011
MIFTS: 47

Microinvasive Gastric Cancer

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Microinvasive Gastric Cancer

MalaCards integrated aliases for Microinvasive Gastric Cancer:

Name: Microinvasive Gastric Cancer 12 15
Early Gastric Cancer 12 56 15 74
Surface Gastric Cancer 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10541
NCIt 51 C27131
UMLS 74 C0349530

Summaries for Microinvasive Gastric Cancer

MalaCards based summary : Microinvasive Gastric Cancer, also known as early gastric cancer, is related to gastric cancer and peptic esophagitis, and has symptoms including abdominal pain and dyspepsia. An important gene associated with Microinvasive Gastric Cancer is TDRG1 (Testis Development Related 1), and among its related pathways/superpathways are Pathways in cancer and Gastric cancer. The drugs Rabeprazole and Pantoprazole have been mentioned in the context of this disorder. Affiliated tissues include lymph node, liver and bone, and related phenotypes are digestive/alimentary and neoplasm

Related Diseases for Microinvasive Gastric Cancer

Diseases related to Microinvasive Gastric Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 213)
# Related Disease Score Top Affiliating Genes
1 gastric cancer 30.8 CDH1 CDX2 MLH1 TDRG1 TP53 VEGFC
2 peptic esophagitis 30.0 ATP12A ATP4A
3 tubular adenocarcinoma 30.0 CDH1 CDX2
4 hernia, hiatus 29.9 ATP12A ATP4A
5 gastric neuroendocrine neoplasm 29.7 ATP12A ATP4A
6 familial adenomatous polyposis 29.6 CDH1 MLH1 TP53
7 esophageal varix 29.6 ATP12A ATP4A
8 pseudomyxoma peritonei 29.4 CDX2 TP53
9 cholangiocarcinoma 29.1 CDH1 CDX2 TP53 VEGFC
10 esophageal cancer 29.0 BCYRN1 CDH1 CDX2 TP53 VEGFC XIST
11 gastric lymphoma 29.0 ATP12A ATP4A TP53
12 gastric adenocarcinoma 29.0 CDH1 CDX2 MLH1 TP53 VEGFC
13 gastric diffuse adenocarcinoma 10.3 CDH1 CDX2
14 adenosquamous colon carcinoma 10.3 CDX2 MLH1
15 gastric signet ring cell adenocarcinoma 10.3 CDH1 CDX2
16 adenoma 10.3
17 signet ring cell adenocarcinoma 10.3 CDH1 CDX2
18 helicobacter pylori infection 10.3
19 adenocarcinoma 10.3
20 gastritis 10.3
21 degos 'en cocarde' erythrokeratoderma 10.3
22 lymphoma 10.2
23 cecum adenocarcinoma 10.1 CDX2 MLH1
24 liver cirrhosis 10.1
25 situs inversus 10.1
26 fungal esophagitis 10.1 ATP12A ATP4A
27 dextrocardia with situs inversus 10.1
28 diclofenac allergy 10.1 ATP12A ATP4A
29 gastroduodenal crohn's disease 10.1 ATP12A ATP4A
30 neonatal candidiasis 10.1 ATP12A ATP4A
31 photoallergic dermatitis 10.1 ATP12A ATP4A
32 squamous papillomatosis 10.1 ATP12A ATP4A
33 cerebral convexity meningioma 10.1 CDH1 TP53
34 toxic megacolon 10.1 ATP12A ATP4A
35 aspiration pneumonitis 10.1 ATP12A ATP4A
36 gastrointestinal neuroendocrine benign tumor 10.1 ATP12A ATP4A
37 gastric antral vascular ectasia 10.1 ATP12A ATP4A
38 granulomatous gastritis 10.1 ATP12A ATP4A
39 esophageal candidiasis 10.1 ATP12A ATP4A
40 acute laryngitis 10.1 ATP12A ATP4A
41 laryngitis 10.1 ATP12A ATP4A
42 duodenitis 10.1 ATP12A ATP4A
43 rumination disorder 10.1 ATP12A ATP4A
44 active peptic ulcer disease 10.1 ATP12A ATP4A
45 congenital disorder of deglycosylation 10.1 ATP12A ATP4A
46 bladder calculus 10.1 ATP12A ATP4A
47 ischemic neuropathy 10.1 ATP12A ATP4A
48 capillary disease 10.1 ATP12A ATP4A
49 dyskinesia of esophagus 10.1 ATP12A ATP4A
50 anismus 10.0 ATP12A ATP4A

Graphical network of the top 20 diseases related to Microinvasive Gastric Cancer:



Diseases related to Microinvasive Gastric Cancer

Symptoms & Phenotypes for Microinvasive Gastric Cancer

UMLS symptoms related to Microinvasive Gastric Cancer:


abdominal pain, dyspepsia

MGI Mouse Phenotypes related to Microinvasive Gastric Cancer:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.43 ATP12A ATP4A CDH1 CDX2 MLH1 TP53
2 neoplasm MP:0002006 9.02 ATP4A CDH1 CDX2 MLH1 TP53

Drugs & Therapeutics for Microinvasive Gastric Cancer

Drugs for Microinvasive Gastric Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 124)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Rabeprazole Approved, Investigational Phase 4,Phase 3 117976-89-3 5029
2
Pantoprazole Approved Phase 4,Not Applicable 102625-70-7 4679
3
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
4
Clopidogrel Approved Phase 4 120202-66-6, 113665-84-2 60606
5
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
6
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
7
Ecabet Investigational Phase 4 86408-72-2, 33159-27-2 65781
8 Antacids Phase 4,Phase 3,Not Applicable
9 Anti-Ulcer Agents Phase 4,Phase 3,Not Applicable
10 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
11 Proton Pump Inhibitors Phase 4,Phase 3,Not Applicable
12 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
13 Platelet Aggregation Inhibitors Phase 4
14 Anti-Inflammatory Agents Phase 4,Not Applicable
15 Purinergic P2Y Receptor Antagonists Phase 4
16 Cyclooxygenase Inhibitors Phase 4
17 Antirheumatic Agents Phase 4
18 Fibrinolytic Agents Phase 4
19 Anti-Inflammatory Agents, Non-Steroidal Phase 4
20 Analgesics Phase 4,Phase 3,Phase 2,Not Applicable
21 Purinergic P2 Receptor Antagonists Phase 4
22 Analgesics, Non-Narcotic Phase 4,Not Applicable
23 Antipyretics Phase 4
24 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
25 Anti-Infective Agents Phase 4,Phase 3
26 HIV Protease Inhibitors Phase 4,Not Applicable
27 Protective Agents Phase 4,Not Applicable
28
protease inhibitors Phase 4,Not Applicable
29 Anesthetics Phase 4,Phase 3,Not Applicable
30 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
31 Hormones Phase 4,Not Applicable
32 Calcium, Dietary Phase 4
33 Anti-Arrhythmia Agents Phase 4
34 Tocolytic Agents Phase 4
35 Anticonvulsants Phase 4
36 calcium channel blockers Phase 4
37
Meperidine Approved Phase 3 57-42-1 4058
38
Midazolam Approved, Illicit Phase 3,Not Applicable 59467-70-8 4192
39
Menthol Approved Phase 3 2216-51-5 16666
40
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613
41
Clarithromycin Approved Phase 3 81103-11-9 84029
42
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
43 GABA Modulators Phase 3,Not Applicable
44 Hypnotics and Sedatives Phase 3,Not Applicable
45 GABA Agents Phase 3,Not Applicable
46 Anesthetics, Intravenous Phase 3,Not Applicable
47 Tranquilizing Agents Phase 3,Not Applicable
48 Anti-Anxiety Agents Phase 3,Not Applicable
49 Adjuvants, Anesthesia Phase 3,Not Applicable
50 Analgesics, Opioid Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 93)
# Name Status NCT ID Phase Drugs
1 Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. Unknown status NCT02638584 Phase 4 Ilaprazole;Rabeprazole
2 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel;aspirin and/or clopidogrel
3 Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection Unknown status NCT01308177 Phase 4 Ecabet
4 The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study Completed NCT02235246 Phase 4 Magnesium Sulfate;Normal saline
5 Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Unknown status NCT01157598 Phase 3
6 Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients Unknown status NCT02246153 Phase 3
7 Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) Unknown status NCT01609309 Phase 3
8 Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301) Completed NCT00546468 Phase 3
9 Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy Completed NCT01411176 Phase 3 Menthol;Placebo
10 Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases Completed NCT02219529 Phase 3
11 Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy Recruiting NCT02595086 Phase 3
12 A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer Recruiting NCT02748551 Phase 3
13 Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy Active, not recruiting NCT01804998 Phase 3
14 Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD Active, not recruiting NCT02407119 Phase 3 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin;Placebo, Omeprazole or Rabeprazole, Clarithromycin
15 Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients Unknown status NCT02644148 Phase 2
16 Phase II Study for Robot Assisted Distal Gastrectomy Unknown status NCT01504997 Phase 2
17 The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric Unknown status NCT02694081 Phase 2
18 The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer Completed NCT02347956 Phase 1, Phase 2
19 Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy Completed NCT02522598 Phase 2 VVZ-149 injections;Placebo
20 Laparoscopic Gastrectomy for Advanced Gastric Cancer Completed NCT01441336 Phase 2
21 Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) Recruiting NCT03837301 Phase 2
22 Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma Recruiting NCT03814759 Phase 2 TS-1 + cisplatin
23 Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients Recruiting NCT03564834 Phase 2
24 The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer Unknown status NCT02710838 Not Applicable
25 Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer Unknown status NCT01659632
26 the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer Unknown status NCT02385578 Not Applicable
27 Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer Unknown status NCT01832246
28 Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer Unknown status NCT01132469 Not Applicable
29 Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection Unknown status NCT02037399 Not Applicable intravenous dexamethasone;intravenous normal saline
30 Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection Unknown status NCT02090062
31 Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer Unknown status NCT01774266
32 The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population Unknown status NCT01490541
33 Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With Diabetes Mellitus Unknown status NCT01375738 Not Applicable
34 Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QC Unknown status NCT01283893
35 Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer Unknown status NCT01742806 Not Applicable
36 Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial Unknown status NCT01179724 Not Applicable high dose proton pump inhibitor;H2RB
37 PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma Unknown status NCT02515721 Not Applicable
38 The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia (GIM) Unknown status NCT01491724
39 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Completed NCT02562976
40 Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients Completed NCT01643811
41 Endoscopic Submucosal Dissection Versus Gastrectomy Completed NCT02216110
42 Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer Completed NCT01544413 Not Applicable
43 Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection Completed NCT02189226 Not Applicable
44 Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy Completed NCT00851305 Not Applicable
45 Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer Completed NCT01943253 Not Applicable
46 Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB Completed NCT02738294 Not Applicable
47 Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer Completed NCT01617876
48 Endoscopic Submucosal Dissection (ESD)- Master Slave Robotic System - Human Study Completed NCT01394861 Early Phase 1
49 Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring Completed NCT01921283 Not Applicable no- BIS sensor attachment
50 Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer Completed NCT01813994 Not Applicable Arm1: Statin;Arm2: Placebo

Search NIH Clinical Center for Microinvasive Gastric Cancer

Genetic Tests for Microinvasive Gastric Cancer

Anatomical Context for Microinvasive Gastric Cancer

MalaCards organs/tissues related to Microinvasive Gastric Cancer:

42
Lymph Node, Liver, Bone, Colon, Prostate, Tongue, Thyroid

Publications for Microinvasive Gastric Cancer

Articles related to Microinvasive Gastric Cancer:

(show top 50) (show all 1913)
# Title Authors Year
1
A Diagnostically Challenging Case of Autoimmune Pancreatitis Due to Contamination of the Pathological Specimen with Early Gastric Cancer. ( 30626846 )
2019
2
Underwater endoscopic mucosal resection for remaining early gastric cancer after endoscopic submucosal dissection. ( 30995684 )
2019
3
Early Gastric Cancer: Current Limitations and What Can Be Done to Address Them. ( 30998518 )
2019
4
Early gastric cancer with ball valve syndrome treated by endoscopic submucosal dissection. ( 30838513 )
2019
5
SURVIVAL AND PERIOPERATIVE MORBIDITY OF TOTALLY LAPAROSCOPIC VERSUS OPEN GASTRECTOMY FOR EARLY GASTRIC CANCER: ANALYSIS FROM A SINGLE LATIN AMERICAN CENTRE. ( 30624522 )
2019
6
Safety and feasibility of laparoscopic gastrectomy accompanied by D1+ lymph node dissection for early gastric cancer in elderly patients. ( 29577648 )
2019
7
Risk factors for lymph node metastasis in non-sentinel node basins in early gastric cancer: sentinel node concept. ( 29799060 )
2019
8
Gastric Xanthoma Is a Predictive Marker for Early Gastric Cancer Detected after Helicobacter pylori Eradication. ( 30449773 )
2019
9
Long-term clinical outcomes of endoscopic vs. surgical resection for early gastric cancer with undifferentiated histology. ( 30604260 )
2019
10
FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer. ( 30603905 )
2019
11
Pitfalls in the Interpretation of Publications about Endoscopic Submucosal Dissection of Early Gastric Cancer with Undifferentiated-Type Histology. ( 30650945 )
2019
12
Natural history of early gastric cancer: series of 21 cases. ( 30648138 )
2019
13
A suitable marking method to achieve lateral margin negative in endoscopic submucosal dissection for undifferentiated-type early gastric cancer. ( 30705962 )
2019
14
Association of the Collagen Signature in the Tumor Microenvironment With Lymph Node Metastasis in Early Gastric Cancer. ( 30698615 )
2019
15
Toward More Accurate Understanding of Lymph Node Metastasis Risk in Early Gastric Cancer. ( 30698606 )
2019
16
Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer: a systematic review and meta-analysis. ( 30694909 )
2019
17
Mixed Histology Is a Risk Factor for Lymph Node Metastasis in Early Gastric Cancer. ( 30694766 )
2019
18
Possibility of limited gastrectomy for early gastric cancer located in the upper third of the stomach, based on the distribution of sentinel node basins. ( 30684050 )
2019
19
Impact of examining additional deeper sections on the pathological diagnosis of endoscopically resected early gastric cancer. ( 30681202 )
2019
20
Strategy for Curative Endoscopic Resection of Undifferentiated-Type Early Gastric Cancer. ( 30674183 )
2019
21
A case of early gastric cancer in a patient with splenic vein angioplany. ( 30668718 )
2019
22
Metachronous gastric cancer risk after endoscopic resection of early gastric cancer and H. pylori status. ( 30770974 )
2019
23
Endoscopic management of patients with early gastric cancers before and after endoscopic resection: a review. ( 30756514 )
2019
24
Clinicopathologic characteristics of early gastric cancer according to specific intragastric location. ( 30736729 )
2019
25
Clinical utility of miniprobe endoscopic ultrasonography for prediction of invasion depth of early gastric cancer: A meta-analysis of diagnostic test from PRISMA guideline. ( 30732202 )
2019
26
Stratification of Postsurgical Computed Tomography Surveillance Based on the Extragastric Recurrence of Early Gastric Cancer. ( 30829697 )
2019
27
Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy. ( 30826866 )
2019
28
Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysis. ( 30805782 )
2019
29
Comparison of endoscopic submucosal dissection with surgical gastrectomy for early gastric cancer: An updated meta-analysis. ( 30788042 )
2019
30
Laparoscopic gastrectomy for early gastric cancer and the risk factors of lymph node metastasis. ( 30777995 )
2019
31
A deep neural network improves endoscopic detection of early gastric cancer without blind spots. ( 30861533 )
2019
32
Sentinel Lymph Node Sampling for Early Gastric Cancer-Preliminary Results of A North American Prospective Study. ( 30859424 )
2019
33
Clinical utility of miniprobe endoscopic ultrasonography for prediction of invasion depth of early gastric cancer: A meta-analysis of diagnostic test from PRISMA guideline: Erratum. ( 30855512 )
2019
34
Does Helicobacter pylori Eradication Reduce the Incidence of Metachronous Gastric Cancer After Curative Endoscopic Resection of Early Gastric Cancer: A Systematic Review and Meta-Analysis. ( 30829904 )
2019
35
miR-106b Promotes Metastasis of Early Gastric Cancer by Targeting ALEX1 in Vitro and in Vivo. ( 30907988 )
2019
36
Artificial intelligence for early gastric cancer: early promise and the path ahead. ( 30902205 )
2019
37
Learning Effect of Diagnosing Depth of Invasion Using Non-Extension Sign in Early Gastric Cancer. ( 30889600 )
2019
38
Utility of linked color imaging for endoscopic diagnosis of early gastric cancer. ( 30886507 )
2019
39
Comparable rates of lymph node metastasis and survival between the diffuse-type and intestinal-type early gastric cancer patients: a large population-based study. ( 30885598 )
2019
40
Multimodal multiphoton imaging for label-free monitoring of early gastric cancer. ( 30940105 )
2019
41
Nutritional safety of oncometabolic surgery for early gastric cancer patients: a prospective single-arm pilot study using a historical control group for comparison. ( 30927123 )
2019
42
Early gastric cancer diagnostic ability of ultrathin endoscope loaded with laser light source. ( 30918430 )
2019
43
The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer. ( 30913874 )
2019
44
Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. ( 30983818 )
2019
45
Modified laser-based photodynamic endoscopic diagnosis for early gastric cancer. ( 30983007 )
2019
46
Margin diagnosis for endoscopic submucosal dissection of early gastric cancer using multiphoton microscopy. ( 30972623 )
2019
47
Long-term Clinical Outcomes and Risk of Peritoneal Seeding after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Focus on Perforation during the Procedure. ( 30970443 )
2019
48
Analysis of the factors related to the poor outcome after e-learning training in endoscopic diagnosis of early gastric cancer using magnifying narrow-band imaging. ( 31034809 )
2019
49
Conscious transnasal hybrid endoscopic submucosal dissection enables safe and painless en bloc resection in elderly patients with early gastric cancer. ( 31016274 )
2019
50
Exclusive Cerebellar and Leptomeningeal Metastases from Early Gastric Cancer 14 Months after Proximal Gastrectomy: An Autopsy Case Report. ( 31016104 )
2019

Variations for Microinvasive Gastric Cancer

Expression for Microinvasive Gastric Cancer

Search GEO for disease gene expression data for Microinvasive Gastric Cancer.

Pathways for Microinvasive Gastric Cancer

Pathways related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 12.18 CDH1 MLH1 TP53 VEGFC
2
Show member pathways
11.59 CDH1 CDX2 MLH1 TP53
3 11.35 CDH1 MLH1 TP53

GO Terms for Microinvasive Gastric Cancer

Biological processes related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ATP hydrolysis coupled proton transport GO:0015991 9.4 ATP12A ATP4A
2 resolution of meiotic recombination intermediates GO:0000712 9.37 EME2 MLH1
3 cellular sodium ion homeostasis GO:0006883 9.26 ATP12A ATP4A
4 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.16 ATP12A ATP4A
5 sodium ion transport GO:0006814 9.02 SCN10A
6 cellular potassium ion homeostasis GO:0030007 8.96 ATP12A ATP4A
7 sodium ion export across plasma membrane GO:0036376 8.62 ATP12A ATP4A

Molecular functions related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 8.96 ATP12A ATP4A
2 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP12A ATP4A

Sources for Microinvasive Gastric Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....